Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial (Q42995214)
Jump to navigation
Jump to search
scientific article published on 11 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial |
scientific article published on 11 June 2010 |
Statements
1 reference
Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial (English)
1 reference
Jean-Pierre Després
1 reference
Josep Rodés-Cabau
1 reference
Olivier F Bertrand
1 reference
Paul Poirier
1 reference
Stéphane Rinfret
1 reference
Lawrence M Title
1 reference
Vladimir Dzavik
1 reference
Madhu Natarajan
1 reference
Juan Angel
1 reference
Nuria Batalla
1 reference
Natalie Alméras
1 reference
Olivier Costerousse
1 reference
Robert De Larochellière
1 reference
Louis Roy
1 reference
VICTORY Trial Investigators
1 reference
11 June 2010
1 reference
1 reference
Identifiers
1 reference